G-CSF- and erythropoietin-based cell therapy: a promising strategy for angiomyogenesis in myocardial infarction. [electronic resource]
- Expert review of cardiovascular therapy Jun 2008
- 703-13 p. digital
Publication Type: Journal Article; Review
1744-8344
10.1586/14779072.6.5.703 doi
Animals Cell- and Tissue-Based Therapy--methods Clinical Trials as Topic Combined Modality Therapy Disease Models, Animal Erythropoietin--therapeutic use Granulocyte Colony-Stimulating Factor--therapeutic use Hematopoietic Stem Cell Mobilization Humans Myocardial Infarction--mortality Neovascularization, Physiologic--physiology Regeneration Sensitivity and Specificity Severity of Illness Index Treatment Outcome Ventricular Remodeling--physiology